ALA to Promote Awareness of Progressive Pulmonary Fibrosis
On World Interstitial Lung Disease Day, the American Lung Association launched an initiative to helping PPF patients and caregivers recognize worsening symptoms and lung scarring.
On World Interstitial Lung Disease Day, the American Lung Association launched an initiative to helping PPF patients and caregivers recognize worsening symptoms and lung scarring.
New global guidance and manufacturing initiatives focus on delivering age-appropriate sickle cell therapies to pediatric patients.
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
The American College of Allergy, Asthma, and Immunology (ACAAI) outlines essential steps for families and school staff to navigate seasonal allergy triggers and respiratory health.
ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.
A study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.
Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.
Results from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).